Get the Stockscreener App
3.36
2.33%
-0.08
After Hours:
3.36
Aurora Cannabis Inc. stock is traded at $3.36, with a volume of 604.09K.
It is down -2.33% in the last 24 hours and down -21.13% over the past month.
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. The company has operations in 19 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
See More
Previous Close:
$3.44
Open:
$3.46
24h Volume:
604.09K
Relative Volume:
0.38
Market Cap:
$191.11M
Revenue:
$195.82M
Net Income/Loss:
$-88.78M
P/E Ratio:
-1.3392
EPS:
-2.5089
Net Cash Flow:
$-88.86M
1W Performance:
+1.51%
1M Performance:
-21.13%
6M Performance:
-36.24%
1Y Performance:
-46.92%
1-Day Range:
$3.33
$3.48
1-Week Range:
$3.33
$3.67
52-Week Range:
$3.28
$6.83
Aurora Cannabis Inc. Stock (ACB) Company Profile
Name
Aurora Cannabis Inc.
Sector
Phone
-
Address
10355 Jasper Avenue, Suite 500, Edmonton, AB
Compare ACB vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACB
Aurora Cannabis Inc.
|
3.37 | 195.08M | 195.82M | -88.78M | -88.86M | -2.5089 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.38 | 57.75B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.63 | 56.70B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.92 | 39.96B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
476.07 | 20.49B | 3.13B | 1.27B | 1.12B | 26.39 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Dec-11-24 | Initiated | TD Cowen | Buy |
| Feb-09-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-21-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-24-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jun-06-22 | Upgrade | Stifel | Sell → Hold |
| Sep-28-21 | Upgrade | MKM Partners | Sell → Neutral |
| Sep-03-21 | Upgrade | Jefferies | Underperform → Hold |
| May-14-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-14-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| May-11-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Apr-28-21 | Resumed | BofA Securities | Neutral |
| Feb-12-21 | Downgrade | Desjardins | Hold → Sell |
| Feb-12-21 | Downgrade | MKM Partners | Neutral → Sell |
| Feb-12-21 | Downgrade | Needham | Hold → Underperform |
| Dec-18-20 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-27-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-24-20 | Upgrade | Stifel | Sell → Hold |
| May-22-20 | Downgrade | Jefferies | Hold → Underperform |
| May-15-20 | Upgrade | Piper Sandler | Underweight → Neutral |
| Feb-27-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Feb-25-20 | Initiated | Needham | Hold |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-14-20 | Upgrade | MKM Partners | Sell → Neutral |
| Feb-07-20 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| Jan-10-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-10-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-23-19 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-24-19 | Initiated | CIBC | Neutral |
View All
Aurora Cannabis Inc. Stock (ACB) Latest News
Promising Cannabis Stocks To ConsiderFebruary 11th - MarketBeat
Aurora Advances Global Medical Growth Strategy With Portfolio Expansion in Australia, New Zealand - Cannabis Business Times
Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand - The Globe and Mail
Aurora Cannabis expands medical portfolio in Australia and New Zealand - StreetInsider
Promising Cannabis Stocks To Watch TodayFebruary 10th - MarketBeat
Aurora Cannabis: 3Q Revenue Jumps on Strong Medical Sales – Quarterly Update Report - Yahoo Finance
Aurora Cannabis: 3Q Revenue Jumps on Strong Medical Sales – Downloadable Quarterly Report - Yahoo Finance
Best Cannabis Stocks To ResearchFebruary 9th - MarketBeat
Is Aurora Cannabis Inc impacted by rising ratesWeekly Investment Report & Stock Market Timing Techniques - baoquankhu1.vn
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Cannabis Stocks To Keep An Eye OnFebruary 8th - MarketBeat
Cannabis Stocks To ResearchFebruary 7th - MarketBeat
Aurora Cannabis (OTCMKTS:ACBFF) Shares Down 2.9%Here's What Happened - MarketBeat
Cannabis Stocks To Watch TodayFebruary 6th - MarketBeat
Should you sell your Aurora Cannabis stock? - Cantech Letter
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Best Cannabis Stocks To Keep An Eye OnFebruary 5th - MarketBeat
Aurora Cannabis Launches US$100 Million At-the-Market Equity Program to Fund Growth - The Globe and Mail
Aurora Cannabis Stock Falls After Consumer Sales Plummet - 富途牛牛
Aurora Cannabis Inc. (NASDAQ:ACB) Q3 2026 Earnings Call Transcript - Insider Monkey
Stocks in play: Aurora Cannabis Inc. - Barchart.com
Aurora Cannabis Inc. (ACB): Investor Outlook With A Promising 69.98% Upside Potential - DirectorsTalk Interviews
Aurora Cannabis Q3 FY26 slides highlight record global medical revenue amid strategic expansion - Investing.com Australia
Aurora Cannabis shares dip after Q3 results show modest revenue growth - AlphaStreet News -
Aurora Cannabis Earnings Call Highlights Medical-First Pivot - TipRanks
Aurora Cannabis establishes $100 million at-the-market offering By Investing.com - Investing.com Australia
Promising Cannabis Stocks To Add to Your WatchlistFebruary 4th - MarketBeat
Aurora Cannabis (TSE:ACB) Hits New 1-Year LowShould You Sell? - MarketBeat
Aurora Cannabis Sets Up US$100 Million ATM Equity Program With TD Securities - TipRanks
Investor Outlook: Medical cannabis grows as U.S. reclassification nears - BNN Bloomberg
Aurora Cannabis Inc (ACB) (Q3 2026) Earnings Call Highlights: Strategic Shifts and Global ... By GuruFocus - Investing.com Canada
Aurora Cannabis Inc (ACB) (Q3 2026) Earnings Call Highlights: St - GuruFocus
'The company is one of the strongest balance sheets in the cannabis industry': Aurora Cannabis CEO - BNN Bloomberg
Aurora Cannabis (ACB) Q3 2026 Earnings Transcript - The Globe and Mail
Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results - MarketBeat
Aurora Cannabis Q3 Earnings Call Highlights - MarketBeat
Aurora Cannabis Swings To A Loss In Q3 2026 On Record Medical Revenue - thedeepdive.ca
Q3 2026: Aurora to exit select Canadian consumer markets, doubles down on global medical business - StratCann
Aurora Cannabis (NASDAQ: ACB) launches U.S.$100M at-the-market share program - Stock Titan
Aurora Cannabis announces filing of prospectus supplement for at-the-market offering program - marketscreener.com
Earnings call transcript: Aurora Cannabis Q3 2026 shows revenue growth By Investing.com - Investing.com Canada
Aurora Cannabis Q3 FY26 slides highlight record global medical revenue amid strategic expansion By Investing.com - Investing.com South Africa
Earnings call transcript: Aurora Cannabis Q3 2026 shows revenue growth - Investing.com
Aurora Cannabis launches new websites for European customers - MMJDaily
Aurora Cannabis files prospectus for $100 million share offering program - StreetInsider
Aurora Cannabis Up In US Premarket On Q3 Revenue Beat and Bullish FY26 Expectations - 富途牛牛
Aurora Cannabis (ACB) Projects Significant Revenue Growth by FY2 - GuruFocus
Aurora (ACB) Posts Strong Q3 With Record Revenue And Increased E - GuruFocus
Insights into Aurora Cannabis Q3 Earnings - Benzinga
Aurora Cannabis Q3 Results Highlight Record Medical Revenue and Strategic Refocus on Core Markets - TipRanks
Aurora Cannabis Inc. Stock (ACB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
10.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):